Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 19 of 100
Commentary
Howard Dean: ‘At last, Congress proposes drug pricing reform that works’
By
Howard Dean
September 19, 2023
Retail
Wegovy maker Novo Nordisk leapfrogs LVMH to become Europe’s most valuable company after it takes its ‘miracle’ weight loss drug to the U.K.
By
Prarthana Prakash
September 5, 2023
Commentary
Smoke and mirrors: I’ve been debating Vivek Ramaswamy for 2 years. Here’s how I got past his diversionary tactics
By
Jeffrey Sonnenfeld
August 31, 2023
Commentary
U.S. health care has been in crisis since Nixon–but two economists may have found a way to radically disrupt it
By
John G. Singer
August 10, 2023
Health
Popular weight-loss injectable Wegovy cuts risk of heart attack and stroke by 20%, company says
By
Erin Prater
August 8, 2023
Magazine
Novo Nordisk developed Ozempic and started a weight-loss revolution. Its next moonshot is eliminating obesity altogether
By
Vivienne Walt
July 31, 2023
Health
Ozempic manufacturer Novo Nordisk spent $11 million last year ‘wining and dining’ doctors. Experts slam the move as a breach of doctor-patient trust
By
Erin Prater
July 21, 2023
Newsletters
Digitalization could be the answer to better health care for patients. But first, they need to trust it
By
Eamon Barrett
July 21, 2023
Health
Biden administration pushes Walgreens, CVS and Walmart to tout drug cost benefits of Inflation Reduction Act as drugmakers sue government
By
Riley Griffin
and
Bloomberg
July 19, 2023
Finance
The A.I. mania is so red hot that a small $50 million investment from Nvidia sent an obscure biotech firm’s shares up a record 78%
By
Angel Adegbesan
and
Bloomberg
July 12, 2023
Health
Ozempic isn’t alone. A whole class of ‘revolutionary’ weight-loss drugs is on the market—but only for the wealthy
By
Rachel Shin
July 9, 2023
Success
Eli Lilly’s CEO pinpoints the 3-prong problem big execs face with remote work
By
Jane Thier
June 24, 2023
Features
The maker of Ozempic and Wegovy is researching groundbreaking new drugs to stop people from becoming obese in the first place
By
Vivienne Walt
June 21, 2023
Health
The ADHD drug shortage is spreading as supplies of a popular alternative to Adderall run worryingly low
By
Ike Swetlitz
and
Bloomberg
June 20, 2023
Success
Gen Z needs brand-new skills to climb to the C-suite: ‘What got me here will not get them there,’ says health care CEO
By
Jane Thier
June 2, 2023
Most Popular
Big Tech
The Chan Zuckerberg Initiative cut 70 jobs as the Meta CEO’s philanthropy goes all in on mission to 'cure or prevent...
By
Sydney Lake
Success
U.S. Olympic gold medalist went from $200,000-a-year sponsorship at 20 years old to $12-an-hour internship by 30
By
Orianna Rosa Royle
Future of Work
Ford CEO has 5,000 open mechanic jobs with up to 6-figure salaries from the shortage of manually skilled workers: 'We...
By
Marco Quiroz-Gutierrez